Microscopic Polyangiitis

Rituximab Gains Expanded Approval in Pediatrics

  The Food and Drug Administration has expanded the approval of Rituxan® injection (rituximab) to include the treatment of children ≥2 years of age who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), in combination with glucocorticoids. Rituximab is a CD20-directed cytolytic monoclonal antibody first approved in 1997 to…...

Read more

Maitland, Florida, Internist/Anesthesiologist Ties for First Place in Vasculitis Foundation’s 2019 V-RED Award Program

Dr. Mark Anderson’s research and gut instinct ultimately prevented his wife’s vasculitis from becoming worse. (Maitland, Florida, October 2019) Mark Anderson, MD, shared first place honors in the Vasculitis Foundation’s (VF’s) 2019 Recognizing Excellence in Diagnostics (V-RED) award program. Dr. Anderson’s patient, his wife Nancy Anderson, was trying to get…...

Read more